Published in J Neuropathol Exp Neurol on August 01, 2012
Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. Cancer Cell (2015) 1.49
Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harb Perspect Biol (2015) 0.85
Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro Oncol (2015) 0.83
Signals that regulate the oncogenic fate of neural stem cells and progenitors. Exp Neurol (2013) 0.79
Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes. J Neurosci (2013) 0.78
Hydrogel Environment Supports Cell Culture Expansion of a Grade IV Astrocytoma. Neurochem Res (2017) 0.75
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 19.30
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev (2001) 15.97
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci (1997) 6.74
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis (2001) 6.29
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia (2002) 5.81
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell (2005) 5.51
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet (2000) 5.28
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev (2001) 4.53
Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene (2004) 4.29
Neuronal or glial progeny: regional differences in radial glia fate. Neuron (2003) 3.68
Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell (2007) 3.14
Glioma stem cells: a midterm exam. Neuron (2008) 2.69
Cancer stem cells in radiation resistance. Cancer Res (2007) 2.59
Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol (2006) 2.53
Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell (2012) 2.50
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res (2002) 2.45
The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J Neurosci (2003) 2.44
The molecular and genetic basis of neurological tumours. Nat Rev Cancer (2002) 2.41
Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer (2004) 2.11
Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J (2009) 1.66
Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg (1976) 1.62
Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Cancer Res (2005) 1.47
Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases. Cancer (1991) 1.34
GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma. Mol Cancer Res (2009) 1.09
Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation? J Neuropathol Exp Neurol (2008) 1.04
Genetic profile of the giant cell glioblastoma. Lab Invest (1999) 1.02
Gemistocytic astrocytomas: a reappraisal. J Neurosurg (1991) 0.99
Circumscribed "giant-cell" glioblastoma. Va Med Mon (1918) (1970) 0.77
The index case for the fungal meningitis outbreak in the United States. N Engl J Med (2012) 3.60
Pediatric cerebellar pilomyxoid-spectrum astrocytomas. J Neurosurg Pediatr (2011) 1.82
IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis (2004) 1.39
Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care (2013) 1.26
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib. J Thorac Oncol (2012) 1.18
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus (2009) 1.12
Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS One (2011) 1.03
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol (2011) 0.97
Distinctive MRI features of pediatric medulloblastoma subtypes. AJR Am J Roentgenol (2013) 0.96
Vitamin D deficiency and risk of acute lung injury in severe sepsis and severe trauma: a case-control study. Ann Intensive Care (2014) 0.90
Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsis. Ann Intensive Care (2013) 0.89
Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome. Breast Cancer Res Treat (2014) 0.88
Computational model and microfluidic platform for the investigation of paracrine and autocrine signaling in mouse embryonic stem cells. Mol Biosyst (2009) 0.88
Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice. Cancer Res (2010) 0.86
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing. Clin Colorectal Cancer (2013) 0.85
CITED1 expression in liver development and hepatoblastoma. Neoplasia (2012) 0.84
Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery. Neurosurgery (2009) 0.84
Foramen magnum meningioma: Dysphagia of atypical etiology. J Gen Intern Med (2007) 0.83
Association between -251A>T polymorphism in the interleukin-8 gene and oral cancer risk: a meta-analysis. Gene (2013) 0.82
Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics. J Pediatr Surg (2010) 0.82
Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis. Breast Cancer Res (2014) 0.82
LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of 3 cases. Am J Surg Pathol (2013) 0.81
Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma. Pancreas (2013) 0.81
NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma. Acta Neuropathol Commun (2015) 0.79
Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow. Arch Pathol Lab Med (2015) 0.79
53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer (2013) 0.79
Downregulation of placental S100P is associated with cadmium exposure in Guiyu, an e-waste recycling town in China. Sci Total Environ (2011) 0.78
A phase II study of carboplatin and irinotecan in extensive stage small-cell lung cancer. Clin Lung Cancer (2011) 0.78
Dapsone-induced methemoglobinemia: a dose-related occurrence? Cancer (2011) 0.78
Recurring osteoma within a calcium phosphate bone cement cranioplasty: case report. Neurosurgery (2009) 0.78
Screening for vitamin D insufficiency in pediatric cancer survivors. Pediatr Blood Cancer (2013) 0.77
Fatal antimalarial-induced cardiomyopathy: report of 2 cases. J Clin Rheumatol (2012) 0.76
Antimicrobial activity of electrospun poly(butylenes succinate) fiber mats containing PVP-capped silver nanoparticles. Appl Biochem Biotechnol (2013) 0.76
Single Cell Analysis of Human Tissues and Solid Tumors with Mass Cytometry. Cytometry B Clin Cytom (2017) 0.76
Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy. J Pediatr Surg (2013) 0.75
Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour. Histopathology (2014) 0.75
Effects of astigmatism on spectra, coherence and polarization of stochastic electromagnetic beams passing through an astigmatic optical system. Opt Express (2009) 0.75